Analysis of Killer Cell Activities in Epstein‐Barr Virus Infections

This publication has 19 references indexed in Scilit:

• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
  The Journal of Immunology, 1985
• Immune function in chronic active Epstein-Barr virus infection
  Journal of Clinical Immunology, 1985
• Epstein-Barr Virus Infection and Immunoregulation in Man
  Published by Elsevier ,1985
• Paired epstein‐barr virus‐carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non‐specific and to allo‐specific cytotoxic responses in vitro
  International Journal of Cancer, 1984
• X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
  Journal of Clinical Investigation, 1983
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.
  The Journal of Experimental Medicine, 1979
• X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)
  The Lancet, 1975